keyword
MENU ▼
Read by QxMD icon Read
search

Derek yellon

keyword
https://read.qxmd.com/read/30847415/sglt2-inhibitor-canagliflozin-attenuates-myocardial-infarction-in-the-diabetic-and-nondiabetic-heart
#1
Ven G Lim, Robert M Bell, Sapna Arjun, Maria Kolatsi-Joannou, David A Long, Derek M Yellon
The authors hypothesized that despite similar cardiovascular event rates, the improved cardiovascular survival from sodium glucose transporter 2 (SGLT2) inhibition, seen clinically, could be via a direct cytoprotective effect, including protection against myocardial ischemia/reperfusion injury. Langendorff-perfused hearts, from diabetic and nondiabetic rats, fed long-term for 4 weeks with canagliflozin, had lower infarct sizes; this being the first demonstration of canagliflozin's cardioprotective effect against ischemia/reperfusion injury in both diabetic and nondiabetic animals...
February 2019: JACC. Basic to Translational Science
https://read.qxmd.com/read/30738798/stromal-cell-derived-factor-1%C3%AE-signals-via-the-endothelium-to-protect-the-heart-against-ischaemia-reperfusion-injury
#2
Daniel I Bromage, Stasa Taferner, Zhenhe He, Oliver J Ziff, Derek M Yellon, Sean M Davidson
AIMS: The chemokine stromal derived factor-1α (SDF-1α) is known to protect the heart acutely from ischaemia-reperfusion injury via its cognate receptor, CXCR4. However, the timing and cellular location of this effect, remains controversial. METHODS AND RESULTS: Wild type male and female mice were subjected to 40 min LAD territory ischaemia in vivo and injected with either saline (control) or SDF-1α prior to 2 h reperfusion. Infarct size as a proportion of area at risk was assessed histologically using Evans blue and triphenyltetrazolium chloride...
February 7, 2019: Journal of Molecular and Cellular Cardiology
https://read.qxmd.com/read/30651940/comparison-of-small-extracellular-vesicles-isolated-from-plasma-by-ultracentrifugation-or-size-exclusion-chromatography-yield-purity-and-functional-potential
#3
Kaloyan Takov, Derek M Yellon, Sean M Davidson
Interest in small extracellular vesicles (sEVs) as functional carriers of proteins and nucleic acids is growing continuously. There are large numbers of sEVs in the blood, but lack of standardised methods for sEV isolation greatly limits our ability to study them. In this report, we use rat plasma to systematically compare two commonly used techniques for isolation of sEVs: ultracentrifugation (UC-sEVs) and size-exclusion chromatography (SEC-sEVs). SEC-sEVs had higher particle number, protein content, particle/protein ratios and sEV marker signal than UC-sEVs...
2019: Journal of Extracellular Vesicles
https://read.qxmd.com/read/30621955/multitarget-strategies-to-reduce-myocardial-ischemia-reperfusion-injury-jacc-review-topic-of-the-week
#4
REVIEW
Sean M Davidson, Péter Ferdinandy, Ioanna Andreadou, Hans Erik Bøtker, Gerd Heusch, Borja Ibáñez, Michel Ovize, Rainer Schulz, Derek M Yellon, Derek J Hausenloy, David Garcia-Dorado
Many treatments have been identified that confer robust cardioprotection in experimental animal models of acute ischemia and reperfusion injury. However, translation of these cardioprotective therapies into the clinical setting of acute myocardial infarction (AMI) for patient benefit has been disappointing. One important reason might be that AMI is multifactorial, causing cardiomyocyte death via multiple mechanisms, as well as affecting other cell types, including platelets, fibroblasts, endothelial and smooth muscle cells, and immune cells...
January 8, 2019: Journal of the American College of Cardiology
https://read.qxmd.com/read/30565995/protection-from-cardiac-ischemia-reperfusion-injury-by-epigenetic-regulation-of-nadph-oxidase
#5
EDITORIAL
Sean M Davidson, Derek M Yellon
No abstract text is available yet for this article.
December 11, 2018: Circulation
https://read.qxmd.com/read/30404623/incidence-and-predictors-of-left-ventricular-thrombus-by-cardiovascular-magnetic-resonance-in-acute-st-segment-elevation-myocardial-infarction-treated-by-primary-percutaneous-coronary-intervention-a-meta-analysis
#6
REVIEW
Heerajnarain Bulluck, Mervyn H H Chan, Valeria Paradies, Robert L Yellon, He H Ho, Mark Y Chan, Calvin W L Chin, Jack W Tan, Derek J Hausenloy
INTRODUCTION: The incidence of left ventricular (LV) thrombus formation in ST-segment elevation myocardial infarction (STEMI) patients in the current era of primary percutaneous coronary intervention (PCI) is not well established. We performed a meta-analysis to assess the actual incidence and predictors of LV thrombus by cardiovascular magnetic resonance (CMR) in STEMI treated by primary PCI. METHODS: We searched MEDLINE and EMBASE databases up to February 2018...
November 8, 2018: Journal of Cardiovascular Magnetic Resonance
https://read.qxmd.com/read/30367147/endothelial-cells-release-cardioprotective-exosomes-that-may-contribute-to-ischaemic-preconditioning
#7
Sean M Davidson, Jaime A Riquelme, Ying Zheng, Jose M Vicencio, Sergio Lavandero, Derek M Yellon
Extracellular vesicles (EVs) such as exosomes are nano-sized vesicles that carry proteins and miRNAs and can transmit signals between cells. We hypothesized that exosomes from endothelial cells can transmit protective signals to cardiomyocytes. Co-culture of primary adult rat cardiomyocytes with normoxic HUVEC cells separated by a cell-impermeable membrane reduced the percentage of cardiomyocyte death following simulated ischaemia and reperfusion (sIR) from 80 ± 11% to 51 ± 4% (P < 0.05; N = 5)...
October 26, 2018: Scientific Reports
https://read.qxmd.com/read/30310998/the-10th-biennial-hatter-cardiovascular-institute-workshop-cellular-protection-evaluating-new-directions-in-the-setting-of-myocardial-infarction-ischaemic-stroke-and-cardio-oncology
#8
REVIEW
Sean M Davidson, Sapna Arjun, Maryna V Basalay, Robert M Bell, Daniel I Bromage, Hans Erik Bøtker, Richard D Carr, John Cunningham, Arjun K Ghosh, Gerd Heusch, Borja Ibanez, Petra Kleinbongard, Sandrine Lecour, Helen Maddock, Michel Ovize, Malcolm Walker, Marlene Wiart, Derek M Yellon
Due to its poor capacity for regeneration, the heart is particularly sensitive to the loss of contractile cardiomyocytes. The onslaught of damage caused by ischaemia and reperfusion, occurring during an acute myocardial infarction and the subsequent reperfusion therapy, can wipe out upwards of a billion cardiomyocytes. A similar program of cell death can cause the irreversible loss of neurons in ischaemic stroke. Similar pathways of lethal cell injury can contribute to other pathologies such as left ventricular dysfunction and heart failure caused by cancer therapy...
October 11, 2018: Basic Research in Cardiology
https://read.qxmd.com/read/30120595/practical-guidelines-for-rigor-and-reproducibility-in-preclinical-and-clinical-studies-on-cardioprotection
#9
REVIEW
Hans Erik Bøtker, Derek Hausenloy, Ioanna Andreadou, Salvatore Antonucci, Kerstin Boengler, Sean M Davidson, Soni Deshwal, Yvan Devaux, Fabio Di Lisa, Moises Di Sante, Panagiotis Efentakis, Saveria Femminò, David García-Dorado, Zoltán Giricz, Borja Ibanez, Efstathios Iliodromitis, Nina Kaludercic, Petra Kleinbongard, Markus Neuhäuser, Michel Ovize, Pasquale Pagliaro, Michael Rahbek-Schmidt, Marisol Ruiz-Meana, Klaus-Dieter Schlüter, Rainer Schulz, Andreas Skyschally, Catherine Wilder, Derek M Yellon, Peter Ferdinandy, Gerd Heusch
No abstract text is available yet for this article.
August 17, 2018: Basic Research in Cardiology
https://read.qxmd.com/read/29858664/neural-mechanisms-in-remote-ischaemic-conditioning-in-the-heart-and-brain-mechanistic-and-translational-aspects
#10
REVIEW
Marina V Basalay, Sean M Davidson, Andrey V Gourine, Derek M Yellon
Remote ischaemic conditioning (RIC) is a promising method of cardioprotection, with numerous clinical studies having demonstrated its ability to reduce myocardial infarct size and improve prognosis. On the other hand, there are several clinical trials, in particular those conducted in the setting of elective cardiac surgery, that have failed to show any benefit of RIC. These contradictory data indicate that there is insufficient understanding of the mechanisms underlying RIC. RIC is now known to signal indiscriminately, protecting not only the heart, but also other organs...
June 1, 2018: Basic Research in Cardiology
https://read.qxmd.com/read/29766336/ischaemic-preconditioning-protects-cardiomyocytes-from-anthracycline-induced-toxicity-via-the-pi3k-pathway
#11
Angshuman Maulik, Sean M Davidson, Izabela Piotrowska, Malcolm Walker, Derek M Yellon
PURPOSE: Anthracyclines cause chronic irreversible cardiac failure, but the mechanism remains poorly understood. Emerging data indicate that cardiac damage begins early, suggesting protective modalities delivered in the acute stage may confer prolonged benefit. Ischaemic preconditioning (IPC) activates the pro-survival reperfusion injury salvage kinase (RISK) pathway which involves PI3-kinase and MAPK/ERK1/2. METHODS: We investigated whether simulated IPC (sIPC), in the form of a sublethal exposure to a hypoxic buffer simulating ischaemic conditions followed by reoxygenation, protects primary adult rat cardiomyocytes against anthracycline-induced injury...
May 15, 2018: Cardiovascular Drugs and Therapy
https://read.qxmd.com/read/29666943/the-gtn-patch-a-simple-and-effective-new-approach-to-cardioprotection
#12
Derek M Yellon, Zhenhe He, Rayomand Khambata, Amrita Ahluwalia, Sean M Davidson
There remains a significant un-met need to reduce the extent of myocardial injury caused by ischaemia and reperfusion injury in patients experiencing an ST-elevation MI. Although nitric oxide is central to many cardioprotective strategies currently undergoing investigation, cardioprotection from the delivery of nitrates/nitrites has been inconsistently observed. The route of administration appears to be a critical variable. The glyceryl trinitrate (GTN) patch is commonly used as a simple and practical means of delivering nitric oxide to patients with ischaemic heart disease, but whether acute cardioprotection can be achieved by application of a GTN patch has not been investigated before...
April 17, 2018: Basic Research in Cardiology
https://read.qxmd.com/read/29656359/myocardial-infarct-size-reduction-provided-by-local-and-remote-ischaemic-preconditioning-references-values-from-the-hatter-cardiovascular-institute
#13
COMPARATIVE STUDY
Xavier Rossello, Zhenhe He, Derek M Yellon
PURPOSE: To accurately estimate the effect size of both local or classic ischaemic preconditioning (IPC) and remote ischaemic preconditioning (RIPC) using a pooling data set of 91 animals. METHODS: We combined all the available mouse data collected from our Institute over the last 3 years regarding (i) local IPC (4 cycles of 5 min of global ischaemia/reperfusion injury, IRI, followed by 35-min ischaemia and 2-h reperfusion) in the Langendorff-isolated perfused mouse heart model and (ii) RIPC (3 cycles of 5 min of limb occlusion followed by 40-min ischaemia and 2-h reperfusion) in the in vivo mouse model...
April 2018: Cardiovascular Drugs and Therapy
https://read.qxmd.com/read/29584817/cardioprotection-is-no-the-answer-a-renewed-look-at-nitric-oxide-signalling-in-cardiomyocytes
#14
Sean M Davidson, Derek M Yellon
No abstract text is available yet for this article.
May 1, 2018: Cardiovascular Research
https://read.qxmd.com/read/29582211/the-caspase-1-inhibitor-vx-765-protects-the-isolated-rat-heart-via-the-risk-pathway
#15
Helison Do Carmo, Sapna Arjun, Orlando Petrucci, Derek M Yellon, Sean M Davidson
PURPOSE: Protecting the heart from ischaemia-reperfusion (IR) injury is a major goal in patients presenting with an acute myocardial infarction. Pyroptosis is a novel form of cell death in which caspase 1 is activated and cleaves interleukin 1β. VX-785 is a highly selective, prodrug caspase 1 inhibitor that is also clinically available. It has been shown to be protective against acute IR in vivo rat model, and therefore might be a promising possibility for future cardioprotective therapy...
April 2018: Cardiovascular Drugs and Therapy
https://read.qxmd.com/read/29184625/confounding-factors-in-vesicle-uptake-studies-using-fluorescent-lipophilic-membrane-dyes
#16
Kaloyan Takov, Derek M Yellon, Sean M Davidson
Small extracellular vesicles (sEVs) such as exosomes are nanocarriers of proteins, RNAs and DNAs. Isolation of pure sEV populations remains challenging, with reports of protein and lipoprotein contaminants in the isolates. Cellular uptake - a cornerstone for understanding exosome and sEV function - is frequently examined using lipophilic dyes such as PKH67 or CellMask to label the vesicles. In this study, we investigated whether contaminants can confound the outcomes from sEV and exosomes uptake experiments...
2017: Journal of Extracellular Vesicles
https://read.qxmd.com/read/29169473/xenon-a-noble-member-of-the-cardioprotection-club
#17
EDITORIAL
Derek M Yellon, Xavier Rossello
No abstract text is available yet for this article.
November 28, 2017: Journal of the American College of Cardiology
https://read.qxmd.com/read/29159980/role-of-pi3k-in-myocardial-ischaemic-preconditioning-mapping-pro-survival-cascades-at-the-trigger-phase-and-at-reperfusion
#18
Xavier Rossello, Jaime A Riquelme, Sean M Davidson, Derek M Yellon
The Reperfusion Injury Salvage Kinase (RISK) pathway is considered the main pro-survival kinase cascade mediating the ischaemic preconditioning (IPC) cardioprotective effect. To assess the role of PI3K-Akt, its negative regulator PTEN and other pro-survival proteins such as ERK and STAT3 in the context of IPC, C57BL/6 mouse hearts were retrogradely perfused in a Langendorff system and subjected to 4 cycles of 5 min. ischaemia and 5 min. reperfusion prior to 35 min. of global ischaemia and 120 min. of reperfusion...
February 2018: Journal of Cellular and Molecular Medicine
https://read.qxmd.com/read/29143177/the-risk-pathway-and-beyond
#19
REVIEW
Xavier Rossello, Derek M Yellon
Research on cardioprotection has attracted considerable attention during the past 30 years following the discovery of ischemic preconditioning with great advances being made in the field, particularly in the description of the molecular signalling behind this cardioprotective intervention. In a time when basic research is struggling to translate its findings into therapies in the clinical setting, this viewpoint has the intention of presenting to clinical and basic scientists how the reperfusion injury salvage kinase pathway has been described and dissected, as well as highlighting its relevance in cardioprotection...
November 15, 2017: Basic Research in Cardiology
https://read.qxmd.com/read/29122678/exosomes-and-cardioprotection-a-critical-analysis
#20
REVIEW
Sean M Davidson, Derek M Yellon
Exosomes are nano-sized vesicles released by numerous cell types that appear to have diverse beneficial effects on the injured heart. Studies using exosomes from stem cells or from the blood have indicated that they are able to protect the heart both in models of acute ischaemia and reperfusion, and during chronic ischaemia. In addition to decreasing initial infarct size, they are able to stimulate angiogenesis, reduce fibrosis and remodelling, alter immune cell function and improve long-term cardiac contractile function...
April 2018: Molecular Aspects of Medicine
keyword
keyword
108101
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"